Lataa...
Obeticholic acid improves hepatic steatosis and inflammation by inhibiting NLRP3 inflammasome activation
Background and Aim: Several pre-clinical and clinical researches have proved that obeticholic acid (OCA)has a potential therapeutic effect on non-alcoholic steatohepatitis (NASH). Our aim was to investigate whether the therapeutic effect of OCA on NASH was attributed to its inhibition effect on cyto...
Tallennettuna:
| Julkaisussa: | Int J Clin Exp Pathol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
e-Century Publishing Corporation
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6965461/ https://ncbi.nlm.nih.gov/pubmed/31966664 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|